BioCatalyst

ANNX — Annexon, Inc. catalysts

2 verified catalyst event(s) for Annexon, Inc. (ticker ANNX). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-10-31 — A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprum · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-31
in 1mo
ESTIMATED
 READOUT
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections o
Phase 3 · Geographic Atrophy
 ANNX Annexon, Inc. Vonaprument ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as AN
Phase 3 · Guillain-Barre Syndrome
 ANNX Annexon, Inc. Tanruprubart ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.